Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Tharimmune, Inc. Director's Dealing 2025

Mar 27, 2025

34824_dirs_2025-03-27_101f228e-49b8-4e41-82db-865f5ed7689f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-03-27

Reporting Person: Kim Dong (CFO)

More from Tharimmune, Inc.

Interim / Quarterly Report 2026
May 13
Annual Report 2026
Mar 31
Regulatory Filings 2026
Mar 31
Regulatory Filings 2026
Mar 3
Regulatory Filings 2026
Mar 3
Regulatory Filings 2026
Feb 18
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 11
View all filings →